|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CENPF-EGLN1 (FusionGDB2 ID:HG1063TG54583) |
Fusion Gene Summary for CENPF-EGLN1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CENPF-EGLN1 | Fusion gene ID: hg1063tg54583 | Hgene | Tgene | Gene symbol | CENPF | EGLN1 | Gene ID | 1063 | 54583 |
| Gene name | centromere protein F | egl-9 family hypoxia inducible factor 1 | |
| Synonyms | CENF|CILD31|PRO1779|STROMS|hcp-1 | C1orf12|ECYT3|HALAH|HIF-PH2|HIFPH2|HPH-2|HPH2|PHD2|SM20|ZMYND6 | |
| Cytomap | ('CENPF')('EGLN1') 1q41 | 1q42.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | centromere protein FAH antigenCENP-F kinetochore proteincell-cycle-dependent 350K nuclear proteincentromere protein F, 350/400kDakinetochore protein CENPFmitosin | egl nine homolog 1HIF-prolyl hydroxylase 2egl nine-like protein 1hypoxia-inducible factor prolyl hydroxylase 2prolyl hydroxylase domain-containing protein 2zinc finger MYND domain-containing protein 6 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P49454 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000366955, ENST00000467765, | ||
| Fusion gene scores | * DoF score | 6 X 5 X 3=90 | 7 X 4 X 5=140 |
| # samples | 5 | 7 | |
| ** MAII score | log2(5/90*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/140*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: CENPF [Title/Abstract] AND EGLN1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CENPF(214795624)-EGLN1(231509845), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | CENPF-EGLN1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CENPF-EGLN1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CENPF | GO:0015031 | protein transport | 12974617 |
| Hgene | CENPF | GO:0045892 | negative regulation of transcription, DNA-templated | 15677469 |
| Hgene | CENPF | GO:0051310 | metaphase plate congression | 15870278 |
| Tgene | EGLN1 | GO:0001666 | response to hypoxia | 16956324 |
| Tgene | EGLN1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 11598268 |
| Tgene | EGLN1 | GO:0032364 | oxygen homeostasis | 16956324 |
| Tgene | EGLN1 | GO:0043433 | negative regulation of DNA-binding transcription factor activity | 16956324 |
| Tgene | EGLN1 | GO:0071731 | response to nitric oxide | 21601578 |
| Fusion gene breakpoints across CENPF (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across EGLN1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | LUSC | TCGA-56-7582-01A | CENPF | chr1 | 214795624 | + | EGLN1 | chr1 | 231509845 | - |
Top |
Fusion Gene ORF analysis for CENPF-EGLN1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000366955 | ENST00000476717 | CENPF | chr1 | 214795624 | + | EGLN1 | chr1 | 231509845 | - |
| In-frame | ENST00000366955 | ENST00000366641 | CENPF | chr1 | 214795624 | + | EGLN1 | chr1 | 231509845 | - |
| intron-3CDS | ENST00000467765 | ENST00000366641 | CENPF | chr1 | 214795624 | + | EGLN1 | chr1 | 231509845 | - |
| intron-5UTR | ENST00000467765 | ENST00000476717 | CENPF | chr1 | 214795624 | + | EGLN1 | chr1 | 231509845 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000366955 | CENPF | chr1 | 214795624 | + | ENST00000366641 | EGLN1 | chr1 | 231509845 | - | 4286 | 1236 | 168 | 1625 | 485 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000366955 | ENST00000366641 | CENPF | chr1 | 214795624 | + | EGLN1 | chr1 | 231509845 | - | 0.000107348 | 0.9998926 |
Top |
Fusion Genomic Features for CENPF-EGLN1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
Top |
Fusion Protein Features for CENPF-EGLN1 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:214795624/chr1:231509845) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CENPF | . |
| FUNCTION: Required for kinetochore function and chromosome segregation in mitosis. Required for kinetochore localization of dynein, LIS1, NDE1 and NDEL1. Regulates recycling of the plasma membrane by acting as a link between recycling vesicles and the microtubule network though its association with STX4 and SNAP25. Acts as a potential inhibitor of pocket protein-mediated cellular processes during development by regulating the activity of RB proteins during cell division and proliferation. May play a regulatory or permissive role in the normal embryonic cardiomyocyte cell cycle and in promoting continued mitosis in transformed, abnormally dividing neonatal cardiomyocytes. Interaction with RB directs embryonic stem cells toward a cardiac lineage. Involved in the regulation of DNA synthesis and hence cell cycle progression, via its C-terminus. Has a potential role regulating skeletal myogenesis and in cell differentiation in embryogenesis. Involved in dendritic cell regulation of T-cell immunity against chlamydia. {ECO:0000269|PubMed:12974617, ECO:0000269|PubMed:17600710, ECO:0000269|PubMed:7542657, ECO:0000269|PubMed:7651420}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 13_131 | 356 | 3115.0 | Coiled coil | Ontology_term=ECO:0000255 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 1196_1244 | 356 | 3115.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 1549_1646 | 356 | 3115.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 1890_2078 | 356 | 3115.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 2107_2891 | 356 | 3115.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 280_685 | 356 | 3115.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 899_989 | 356 | 3115.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 2919_2936 | 356 | 3115.0 | Motif | Nuclear localization signal |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 2111_2472 | 356 | 3115.0 | Region | Note=2 X 177 AA tandem repeats |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 2392_2829 | 356 | 3115.0 | Region | Note=Sufficient for self-association |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 2392_3017 | 356 | 3115.0 | Region | Note=Sufficient for centromere localization |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 2831_3017 | 356 | 3115.0 | Region | Note=Sufficient for nuclear localization |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 2111_2290 | 356 | 3115.0 | Repeat | Note=1 |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 2293_2472 | 356 | 3115.0 | Repeat | Note=2 |
| Tgene | EGLN1 | chr1:214795624 | chr1:231509845 | ENST00000366641 | 0 | 5 | 291_392 | 297 | 427.0 | Domain | Fe2OG dioxygenase | |
| Tgene | EGLN1 | chr1:214795624 | chr1:231509845 | ENST00000366641 | 0 | 5 | 241_251 | 297 | 427.0 | Region | Beta(2)beta(3) 'finger-like' loop | |
| Tgene | EGLN1 | chr1:214795624 | chr1:231509845 | ENST00000366641 | 0 | 5 | 6_20 | 297 | 427.0 | Region | Note=Required for nuclear export | |
| Tgene | EGLN1 | chr1:214795624 | chr1:231509845 | ENST00000366641 | 0 | 5 | 21_58 | 297 | 427.0 | Zinc finger | MYND-type |
Top |
Fusion Gene Sequence for CENPF-EGLN1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >15696_15696_1_CENPF-EGLN1_CENPF_chr1_214795624_ENST00000366955_EGLN1_chr1_231509845_ENST00000366641_length(transcript)=4286nt_BP=1236nt AGAAGCGGGCGAATTGGGCACCGGTGGCGGCTGCGGGCAGTTTGAATTAGACTCTGGGCTCCAGCCCGCCGAAGCCGCGCCAGAACTGTA CTCTCCGAGAGGTCGTTTTCCCGTCCCCGAGAGCAAGTTTATTTACAAATGTTGGAGTAATAAAGAAGGCAGAACAAAATGAGCTGGGCT TTGGAAGAATGGAAAGAAGGGCTGCCTACAAGAGCTCTTCAGAAAATTCAAGAGCTTGAAGGACAGCTTGACAAACTGAAGAAGGAAAAG CAGCAAAGGCAGTTTCAGCTTGACAGTCTCGAGGCTGCGCTGCAGAAGCAAAAACAGAAGGTTGAAAATGAAAAAACCGAGGGTACAAAC CTGAAAAGGGAGAATCAAAGATTGATGGAAATATGTGAAAGTCTGGAGAAAACTAAGCAGAAGATTTCTCATGAACTTCAAGTCAAGGAG TCACAAGTGAATTTCCAGGAAGGACAACTGAATTCAGGCAAAAAACAAATAGAAAAACTGGAACAGGAACTTAAAAGGTGTAAATCTGAG CTTGAAAGAAGCCAACAAGCTGCGCAGTCTGCAGATGTCTCTCTGAATCCATGCAATACACCACAAAAAATTTTTACAACTCCACTAACA CCAAGTCAATATTATAGTGGTTCCAAGTATGAAGATCTAAAAGAAAAATATAATAAAGAGGTTGAAGAACGAAAAAGATTAGAGGCAGAG GTTAAAGCCTTGCAGGCTAAAAAAGCAAGCCAGACTCTTCCACAAGCCACCATGAATCACCGCGACATTGCCCGGCATCAGGCTTCATCA TCTGTGTTCTCATGGCAGCAAGAGAAGACCCCAAGTCATCTTTCATCTAATTCTCAAAGAACTCCAATTAGGAGAGATTTCTCTGCATCT TACTTTTCTGGGGAACAAGAGGTGACTCCAAGTCGATCAACTTTGCAAATAGGGAAAAGAGATGCTAATAGCAGTTTCTTTGACAATTCT AGCAGTCCTCATCTTTTGGATCAATTAAAAGCGCAGAATCAAGAGCTAAGAAACAAGATTAATGAGTTGGAACTACGCCTGCAAGGACAT GAAAAAGAAATGAAAGGCCAAGTGAATAAGTTTCAAGAACTCCAACTCCAACTGGAGAAAGCAAAAGTGGAATTAATTGAAAAAGAGAAA GTTTTGAACAAATGTAGGGATGAACTAGTGAGAACAACAGCACAATACGACCAGGCGTCAACCAAGGCCATGGTTGCTTGTTATCCGGGC AATGGAACGGGTTATGTACGTCATGTTGATAATCCAAATGGAGATGGAAGATGTGTGACATGTATATATTATCTTAATAAAGACTGGGAT GCCAAGGTAAGTGGAGGTATACTTCGAATTTTTCCAGAAGGCAAAGCCCAGTTTGCTGACATTGAACCCAAATTTGATAGACTGCTGTTT TTCTGGTCTGACCGTCGCAACCCTCATGAAGTACAACCAGCATATGCTACAAGGTACGCAATAACTGTTTGGTATTTTGATGCAGATGAG AGAGCACGAGCTAAAGTAAAATATCTAACAGGTGAAAAAGGTGTGAGGGTTGAACTCAATAAACCTTCAGATTCGGTCGGTAAAGACGTC TTCTAGAGCCTTTGATCCAGCAATACCCCACTTCACCTACAATATTGTTAACTATTTGTTAACTTGTGAATACGAATAAATGGGATAAAG AAAAATAGACAACCAGTTCGCATTTTAATAAGGAAACAGAAACAACTTTTTGTGTTGCATCAAACAGAAGATTTTGACTGCTGTGACTTT GTACTGCATGATCAACTTCAAATCTGTGATTGCTTACAGGAGGAAGATAAGCTACTAATTGAAAATGGTTTTTACATCTGGATATGAAAT AAGTGCCCTGTGTAGAATTTTTTTCATTCTTATATTTTGCCAGATCTGTTATCTAGCTGAGTTCATTTCATCTCTCCCTTTTTTATATCA AGTTTGAATTTGGGATAATTTTTCTATATTAGGTACAATTTATCTAAACTGAATTGAGAAAAAATTACAGTATTATTCCTCAAAATAACA TCAATCTATTTTTGTAAACCTGTTCATACTATTAAATTTTGCCCTAAAAGACCTCTTAATAATGATTGTTGCCAGTGACTGATGATTAAT TTTATTTTACTTAAAATAAGAAAAGGAGCACTTTAATTACAACTGAAAAATCAGATTGTTTTGTAGTCCTTCCTTACACTAATTTGAACT GTTAAAGATTGCTGCTTTTTTTTTGACATTGTCAATAACGAAACCTAATTGTAAAACAGTCACCATTTACTACCAATAACTTTTAGTTAA TGTTTTACAAGGAAAAAGACACAAGAAGAGTTTAAATTTTTTTGTTTTGTTTTGTTTTTTTGAGACAGTCTTGCTCTGTTACCCAGGCTG GAGGGGAGTGGTGCATTCTTGGCTCACTGCAACCTCCGCCTCCCAGGTTCAAGCAATCCTCCCACCTCAGCCTCCCAACTAGCTGGGACT GCAGGCACACACCACCATGCCTGACTAATTTTTGTATGTTTAGTAGAGACGGGGTTTTGCCATGTTGCCTAGGCTGGGGTTTAAGTTAAA TTTTTTAAAAAACTAAAGTGACTGGCACTAAGTGAACTTGAGATTATCCTCAGCTTCAAGTTCCTAAGATAAGGGCTTTCTTAAGCTTTC AGGTGTATGTATCCTCTAGATGTAGACAATAATGTCCCATTTCTAAGTCTTTTCCTTTTGCTTCTCCTTAAATTGATTGTACTTCCAAAT TTGCTGTTATGTTTTTTTCCTAATACTGTGATCTATCTGATCTGCAGACAAGAACCTTGTCTCTGTTGAAGAGCATCAAGGGGAGATTAT GTACACATTGAAACTGAAGTGTGGTGTTACTGACGGAATGTGCAGTAACTCCTCAGATATCTGTTAAGGCATTTCCCAGATGTGATGCCA GCCTTCTTACCTGTACTGAAAGATGCTTAGCTTAGAAAAAAACAAAACAGATGCAAAATCAGATAATTTTATTTTGTTTCATGGGTTTTC TTATTTACTTTTTAAACAAGGAAGGAATATTAGAAAATCACACAAGGCCTCACATACATGTTATTTAAAGAATGAATTGGGACGGATGTC TTAGACTTCACTTTCCTAGGCTTTTTAGCAAAACCTAAAGGGTGGTATCCATATTTTGCGTGAATTATGGGTGTAAGACCTTGCCCACTT AGGTTTTCTATCTCTGTCCTTGATCTTCTTTGCCAAAATGTGAGTATACAGAAATTTTCTGTATATTTCAACTTAAGACATTTTTAGCAT CTGTATAGTTTGTATTCAATTTGAGACCTTTTCTATGGGAAGCTCAGTAATTTTTATTAAAAGATTGCCATTGCTATTCATGTAAAACAT GGAAAAAAATTGTGTAGTGAAGCCAACAGTGGACTTAGGATGGGATTGAATGTTCAGTATAGTGATCTCACTTAGGAGAATTTGCAGGAG AAAGTGATAGTTTATTGTTTTTTCCTCGCCCATATTCAGTTTTGTTCTACTTCCTCCCCTTCCTTCCAGATGATAACATCACATCTCTAC AGTAAGTGCCTCTGCCAGCCCAACCCAGGAGCGCAAGTTGTCTTTGCCATCTGGTCTATAGTACAGTGCGCGGCGTTAGGCCACAACTCA AAAGCATTATCTTTTTTAGGGTTAGTAGAAATTGTTTTATGTTGATGGGAGGTTTGTTTGATTGTCAAAATGTACAGCCACAGCCTTTTA ATTTGGGAGCCCCTGTTGTCATTCAAATGTGTACCTCTACAGTTGTAAAAAGTATTAGATTCTACTATCTGTGGGTTGTGCTTGCCAGAC AGGTCTTAAATTGTATATTTTTTGGAAAAGTTTATATACTCTCTTAGGAATCATTGTGAAAAGATCAAGAAATCAGGATGGCCATTTATT TAATATCCATTCATTTCATGTTAGTGGGACTATTAACTTGTCACCAAGCAGGACTCTATTTCAAACAAAATTTAAAACTGTTTGTGGCCT ATATGTGTTTAATCCTGGTTAAAGATAAAGCTTCATAATGCTGTTTTTATTCAACACATTAACCAGCTGTAAAACACAGACCTTTATCAA GAGTAGGCAAAGATTTTCAGGATTCATATACAGATAGACTATAAAGTCATGTAATTTGAAAAGCAGTGTTTCATTATGAAAGAGCTCTCA >15696_15696_1_CENPF-EGLN1_CENPF_chr1_214795624_ENST00000366955_EGLN1_chr1_231509845_ENST00000366641_length(amino acids)=485AA_BP=356 MSWALEEWKEGLPTRALQKIQELEGQLDKLKKEKQQRQFQLDSLEAALQKQKQKVENEKTEGTNLKRENQRLMEICESLEKTKQKISHEL QVKESQVNFQEGQLNSGKKQIEKLEQELKRCKSELERSQQAAQSADVSLNPCNTPQKIFTTPLTPSQYYSGSKYEDLKEKYNKEVEERKR LEAEVKALQAKKASQTLPQATMNHRDIARHQASSSVFSWQQEKTPSHLSSNSQRTPIRRDFSASYFSGEQEVTPSRSTLQIGKRDANSSF FDNSSSPHLLDQLKAQNQELRNKINELELRLQGHEKEMKGQVNKFQELQLQLEKAKVELIEKEKVLNKCRDELVRTTAQYDQASTKAMVA CYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYF -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CENPF-EGLN1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 2026_2351 | 356.0 | 3115.0 | NDE1 and NDEL1 |
| Hgene | CENPF | chr1:214795624 | chr1:231509845 | ENST00000366955 | + | 7 | 20 | 1_481 | 356.0 | 3115.0 | SNAP25 and required for localization to the cytoplasm |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CENPF-EGLN1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CENPF-EGLN1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CENPF | C1855705 | Jejunal Atresia with Microcephaly and Ocular Anomalies | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
| Hgene | CENPF | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
| Hgene | CENPF | C0025958 | Microcephaly | 1 | GENOMICS_ENGLAND |
| Hgene | CENPF | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Hgene | CENPF | C0265202 | Seckel syndrome | 1 | GENOMICS_ENGLAND |
| Hgene | CENPF | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| Hgene | CENPF | C0678222 | Breast Carcinoma | 1 | CTD_human |
| Hgene | CENPF | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
| Hgene | CENPF | C1292778 | Chronic myeloproliferative disorder | 1 | GENOMICS_ENGLAND |
| Hgene | CENPF | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| Hgene | CENPF | C2239176 | Liver carcinoma | 1 | CTD_human |
| Hgene | CENPF | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
| Tgene | C1708353 | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 6 | CLINGEN | |
| Tgene | C1853286 | Erythrocytosis, Familial, 3 | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
| Tgene | C0030421 | Paraganglioma | 1 | GENOMICS_ENGLAND | |
| Tgene | C0031511 | Pheochromocytoma | 1 | GENOMICS_ENGLAND | |
| Tgene | C0032461 | Polycythemia | 1 | GENOMICS_ENGLAND | |
| Tgene | C0149504 | Encephalopathy, Toxic | 1 | CTD_human | |
| Tgene | C0154659 | Toxic Encephalitis | 1 | CTD_human | |
| Tgene | C0235032 | Neurotoxicity Syndromes | 1 | CTD_human | |
| Tgene | C4551683 | Adrenal Gland Pheochromocytoma | 1 | GENOMICS_ENGLAND |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies